The Evolving Landscape of Anal Cancer Treatments: Incyte's Zynyz Takes Center Stage The anal cancer treatment market is evolving rapidly, led by Incyte's PD-1 inhibitor Zynyz and its competitive landscape involving Merck, Novartis, and others.

The Evolving Landscape of Anal Cancer Treatments: Incyte's Zynyz Takes Center Stage #USA #Las_Vegas #Cancer_Treatments #Incyte_Zynyz #Anal_Cancer